These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11084102)

  • 1. Matching cardiac rhythm management technology to patient needs: pacing/ablation/implantable cardioverter defibrillators.
    Cannom DS
    Am J Cardiol; 2000 Nov; 86(9A):58K-70K. PubMed ID: 11084102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of ventricular arrhythmias: detection, drugs, and devices.
    Cannom DS; Prystowsky EN
    JAMA; 1999 Jan; 281(2):172-9. PubMed ID: 9917122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 5. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
    Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence rather than costs must guide use of the implantable cardioverter defibrillator.
    Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L
    Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J; Abdelhadi R
    Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 16. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Okada DR; Smith J; Derakhshan A; Gowani Z; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
    Circulation; 2018 Sep; 138(12):1253-1264. PubMed ID: 30354431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ventricular arrhythmias: What's New?
    Markman TM; Nazarian S
    Trends Cardiovasc Med; 2019 Jul; 29(5):249-261. PubMed ID: 30268648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias.
    Zivin A; Bardy GH
    Am J Cardiol; 1999 Nov; 84(9A):63R-68R. PubMed ID: 10568662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.